US OptionsDetailed Quotes
RIGL241220P14000
- 0.03
- 0.000.00%
15min DelayClose Dec 12 16:00 ET
0.00High0.00Low
0.03Open0.03Pre Close0 Volume9 Open Interest14.00Strike Price0.00Turnover110.76%IV26.51%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier8DDays to Expiry0.03Extrinsic Value100Contract SizeAmericanOptions Type-0.0244Delta0.0185Gamma633.67Leverage Ratio-0.0103Theta-0.0001Rho-15.44Eff Leverage0.0016Vega
Rigel Pharmaceuticals Stock Discussion
whoa! some Dip
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk MDS
Rigel Pharmaceuticals (Nasdaq: RIGL) announced that the FDA has granted Fast Track designation to R289 for treating patients with previously-treated transfusion dependent lower-risk myelodysplastic syndrome (LR-MDS). R289, a dual inhibitor of IRAK1 and IRAK4, is currently being evaluated in a Phase 1b study. The Fast Track designation may provide benefits including more freque...
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk Mds
Let's break 30.+
27.+
Let's Get 30.+
No comment yet